The A-TAC inventory has previously been employed and validated in epidemiological contexts, yet its validation against thorough clinical diagnostic assessments had remained unestablished in broad population settings. Recognizing this gap, the researchers embarked on a detailed investigation leveraging data from the Child and Adolescent Twin Study in Sweden (CATSS), a longitudinal cohort recruiting twins nationwide. The study meticulously evaluated 263 children, focusing on those who screened positive for neuropsychiatric problems and contrasting them with twin pairs who showed no such concerns in initial screenings.

A core strength of this study lies in the comprehensive clinical examinations performed within a year following the A-TAC interviews. This temporal proximity ensured that the validity of the A-TAC screening could be assessed with high precision against clinical realities. The engagement of clinical experts in child psychiatry enabled an exhaustive evaluation of neurodevelopmental disorders such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), tic disorders, and developmental coordination disorder, among others.

Quantitative psychometric analyses revealed that the A-TAC possesses strong screening potential to discriminate children with clinically diagnosed neurodevelopmental disorders from control participants. The discriminative capability, quantified by the area under the receiver operating characteristic curve (AUC), ranged impressively from 0.806 to 0.958 for most neurodevelopmental categories. This indicates that A-TAC is a highly sensitive and specific tool in detecting conditions like ASD, ADHD, and tics within a non-clinical population.

However, the study highlights a notable exception: the performance of A-TAC in screening for developmental coordination disorder (DCD) was comparatively weaker, with an AUC of 0.616. This suggests that while A-TAC is generally effective, certain neurodevelopmental conditions pose challenges in accurate early detection through parent-report inventories and may necessitate more specialized clinical approaches.

Beyond individual diagnoses, the researchers painted a complex picture of neurodevelopmental comorbidity. Their data articulate that over 40% of children meeting diagnostic criteria for one neurodevelopmental disorder concurrently meet criteria for at least one additional disorder. This finding underscores the multifaceted and overlapping nature of neuropsychiatric conditions in childhood, advocating for diagnostic frameworks that accommodate comorbidity rather than isolated categorical distinctions.

The implications for clinical practice are profound. The study emphasizes the necessity for clinicians to maintain a broad and inclusive diagnostic perspective when assessing child psychiatric cases, given the prevalence of overlapping symptomatology and co-occurring disorders. The use of tools like A-TAC can assist in initial screenings but must be integrated with comprehensive clinical assessments to facilitate accurate diagnosis and appropriate intervention planning.

Importantly, the study cautions against relying solely on A-TAC as a gatekeeping measure for specialized care access. While informative about neurodevelopmental problems, the inventory cannot substitute for clinical neurodevelopmental investigations conducted by qualified professionals. This nuanced understanding ensures that screening tools complement rather than replace clinical judgment.

From a research perspective, the validation of A-TAC against robust clinical diagnoses enriches the epidemiological toolkit available for studying neurodevelopmental disorders. Researchers can incorporate A-TAC in large-scale studies with increased confidence regarding its diagnostic accuracy and predictive utility, facilitating the identification of affected individuals in population-based samples.

Given the increasing prevalence and public health burden of neurodevelopmental disorders worldwide, this study arrives at a critical juncture. It bridges the gap between population screening and clinical diagnosis, potentially influencing future screening policies and early intervention strategies. Early identification has long been recognized as key to optimizing developmental outcomes, and validated tools are essential for scalable screening initiatives.

Moreover, the evidence supporting the multi-disorder screening capacity of A-TAC enhances its utility in clinical and research settings, helping to unravel the complex etiological and symptomatic landscapes of childhood neuropsychiatric conditions. The ability to detect tics, ADHD, autism, and related comorbidities simultaneously points to a pragmatic approach in both scientific inquiry and healthcare delivery.

Overall, this research contributes to a more sophisticated understanding of pediatric neuropsychiatric disorders, emphasizing the interplay of diverse symptoms and conditions. The collaboration between epidemiologists and child psychiatrists exemplified by this study may serve as a model for future integrative efforts aimed at refining diagnostic tools and improving mental health outcomes in children.

In conclusion, this extensive validation study reaffirms the value of the A-TAC inventory as a highly effective screening instrument for neurodevelopmental disorders within child populations, while underscoring the indispensable role of clinical diagnostic evaluations. The nuanced portrayal of comorbidities urges a holistic, broad-spectrum assessment framework to capture the true complexity of childhood neuropsychiatric disorders, promising enhanced clinical care and more informed public health policies in the future.

Subject of Research: Validation of the Autism-Tics, ADHD and other Comorbidities inventory (A-TAC) against clinical diagnostic assessments in a population-based sample of children.

Article Title: Thorough clinical child psychiatric diagnostic evaluation and validation of the Autism- Tics, ADHD and other comorbidities inventory (A-TAC) in a population-based sample of 9-year-olds.

Article References:
Halldner, L., Eberhard, S., Lichtenstein, P. et al. Thorough clinical child psychiatric diagnostic evaluation and validation of the Autism- Tics, ADHD and other comorbidities inventory (A-TAC) in a population-based sample of 9-year-olds. BMC Psychiatry 25, 918 (2025). https://doi.org/10.1186/s12888-025-07475-y

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12888-025-07475-y

Dyslexia and dysgraphia are neurodevelopmental disorders that profoundly affect children’s learning. Dyslexia primarily impairs reading and language processing abilities, while dysgraphia manifests as difficulties with handwriting and fine motor skills. Early identification of these disorders is essential to mitigate their long-term impact on academic achievement and socio-emotional development. The team at the University at Buffalo, led by SUNY Distinguished Professor Venu Govindaraju in the Department of Computer Science and Engineering, is pioneering AI methodologies aimed at revolutionizing the screening process, especially in underserved communities where resources like speech-language pathologists and occupational therapists are scarce.

The project builds on decades of pioneering work by Govindaraju and his colleagues in the realm of handwriting recognition, which historically leveraged machine learning and natural language processing to automate mail sorting for the U.S. Postal Service. In this new iteration, the research extends AI’s capabilities to recognize nuanced handwriting patterns indicative of dyslexia and dysgraphia, such as irregular letter formation, inconsistent spacing, spelling errors, and disorganized writing structure. By deciphering these subtle cues from handwritten samples, the AI system offers a multifaceted approach that identifies both motor-based and cognitive markers of these disorders.

While prior research in this domain has concentrated more heavily on dysgraphia due to its discernible motor symptoms, the new study significantly amplifies focus on dyslexia’s more elusive signs. Dyslexia’s hallmark difficulties in language processing do not always prominently manifest in handwriting, complicating early detection efforts. Nevertheless, the research identifies specific behavioral indicators embedded within the act of writing—such as frequent spelling mistakes and letter reversals—that can serve as red flags when analyzed through sophisticated AI algorithms.

A notable challenge the researchers confronted involved the scarcity of handwriting samples available from children, especially those diagnosed with these learning disabilities, to effectively train AI models. To overcome this, the team collected a broad dataset consisting of both paper and digital handwriting samples from kindergarten through fifth-grade students at an elementary school in Reno, Nevada. This ethically approved and anonymized collection effort provided a rich foundation with which the AI system could be trained, validated, and refined to ensure accuracy and real-world applicability.

Integral to the development process was the collaboration with educators, speech-language pathologists, and occupational therapists. Their unique insights ensured the AI tools aligned with practical classroom environments and clinical evaluations. This end-user informed approach not only enhances the tool’s usability but also increases its potential for adoption across various educational and therapeutic settings.

The research further integrates the Dysgraphia and Dyslexia Behavioral Indicator Checklist (DDBIC), co-developed by literacy expert Dr. Abbie Olszewski from the University of Nevada, Reno. The DDBIC catalogues 17 behavioral cues observable before, during, and after writing, offering a standardized framework for symptom identification. The AI models are being trained to autonomously perform the DDBIC screening, streamlining what currently requires specialist evaluation and manual observation.

Central to the technology is a sophisticated suite of AI models tasked with analyzing multiple dimensions of handwriting. These include the detection of motor control difficulties through metrics such as writing speed, pen pressure, and stroke movements; examination of visual handwriting features like letter size, spacing, and slant; and conversion of handwriting to digitized text for linguistic analysis focusing on misspellings, letter reversals, and grammatical errors. Collectively, these models integrate to unearth cognitive as well as physical markers indicative of the disorders.

The culmination of this research is the development of a comprehensive AI assessment tool that synthesizes inputs from various models into a unified diagnostic summary. This holistic evaluation platform not only flags potential neurodevelopmental concerns but could also provide educators and clinicians with actionable insights to tailor early interventions, addressing a crucial bottleneck in early childhood education systems.

Beyond its technological sophistication, the study underscores the potential of AI for social good. By democratizing access to reliable screening tools, it aims to level the playing field for children in underserved and remote regions where trained specialists are often unavailable. Early intervention enabled by such AI tools could transform educational trajectories, preventing the compounding effects of untreated dyslexia and dysgraphia.

While this research is ongoing, its implications resonate widely. It is a rare example of applied AI synergizing with education and healthcare, showcasing how machine learning and natural language processing advancements can directly enhance human well-being. The interdisciplinary nature of this work, incorporating computer science, linguistics, education, and clinical practice, exemplifies the collaborative spirit needed to tackle complex neurodevelopmental challenges.

The initiative is part of the National AI Institute for Exceptional Education, a University at Buffalo-led research consortium focused on developing AI systems that identify and assist children with speech and language processing difficulties. Funding from the U.S. National Science Foundation supports this cutting-edge endeavor, lending critical resources to push the boundaries of AI applications in public health.

Co-authors contributing to this research include Bharat Jayarman, director at the Amrita Institute of Advanced Research and professor emeritus at UB; Srirangaraj Setlur, principal research scientist at the UB Center for Unified Biometrics and Sensors; and doctoral researcher Sahana Rangasrinivasan, who emphasizes the criticality of building AI tools from the standpoint of those who will employ them. Their collective expertise adds profound depth to the project’s interdisciplinary approach.

This latest advancement in AI-powered handwriting analysis marks a promising shift in detection methodology for dyslexia and dysgraphia, promising greater accessibility, speed, and accuracy in diagnosis. By harnessing the power of contemporary AI combined with behavioral science, the University at Buffalo team sets a high bar for innovation in educational technology and neurodevelopmental health, heralding a future where early intervention is not a privilege but a standard available to all children.

Subject of Research: Early Detection of Dyslexia and Dysgraphia Using Artificial Intelligence-Powered Handwriting Analysis

Article Title: University at Buffalo Develops AI-Based Handwriting Analysis Tool for Early Detection of Dyslexia and Dysgraphia in Children

News Publication Date: Not specified in provided text

Web References: DOI: 10.1007/s42979-025-03927-0 (Published in SN Computer Science)

References: Research article published in SN Computer Science; National AI Institute for Exceptional Education project details

Image Credits: Not provided